Assertio Holdings, Inc. - Common Stock (ASRT)

Assertio Therapeutics Inc is a biopharmaceutical company that focuses on developing and commercializing innovative therapeutics to address unmet medical needs in various therapeutic areas

With a commitment to improving patient outcomes, the company specializes in delivering treatments for diseases such as pain and other central nervous system disorders. Assertio employs a range of scientific approaches, including the advancement of specialized drug formulations and targeted delivery systems, in order to enhance efficacy and patient adherence to treatment. Through its innovative product offerings and robust pipeline, Assertio aims to provide effective solutions that empower patients to lead healthier lives.